Finvest
AXTI Semiconductors · AI infrastructure · Optical chips · China exposure · Thesis updated July 14, 2026

AI optics demand is testing AXTI’s limits

01 Running thesis

AI demand meets permit risk

AXTI is a small supplier in a big bottleneck. It makes compound semiconductor substrates, which are the base wafers that other companies build advanced chips and optical devices on. The current excitement is around indium phosphide, or InP, because InP is used in high-speed optical links inside and between AI data centers.

The bull case has sped up. Management says InP backlog has passed $100M, and the company completed a $632.5M capital raise to support Tongmei’s InP capacity expansion. The plan is to double InP capacity in 2026, then double it again in 2027. Gross margin has also been improving as the mix shifts toward higher-value InP products.

The bear case is not about weak demand. It is about access. U.S.-bound InP export permits are still pending, and North America was only 1% of Q1 2026 revenue. Management says it is still serving U.S. hyperscalers through their operations in other regions, but that is not the same as clean, direct access to U.S. customers.

The next year likely turns on three things: whether U.S. export permits arrive, whether the new InP capacity ramps without quality problems, and whether Tongmei’s planned STAR Market IPO moves forward. Co-packaged optics, a way to place optical links closer to computing chips, could become a larger catalyst in late 2027.

May 2026The Q1 2026 10-Q confirmed the product mix, with substrates at 67% of 2025 revenue and raw materials at 33%. It also added tariff relief from the Supreme Court ruling on IEEPA tariffs, while Section 232 and Section 301 tariffs remain.
Apr 2026Q1 earnings made the growth case stronger. Management announced a $632.5M raise for Tongmei InP expansion and said InP backlog had passed $100M.
Mar 2026The 2025 10-K showed progress on permits for Europe and Japan, but U.S. InP permits were still unresolved. North America fell to about 2% of 2025 revenue.
Feb 2026Q4 2025 showed export delays hurting revenue, but early 2026 permits began clearing backlog. Management also laid out a plan to double InP capacity in 2026.
Nov 2025The Q3 2025 10-Q showed that U.S.-bound GaAs permits had not been approved because some customers were viewed as dual use. U.S.-bound InP permits also remained pending.
Oct 2025Q3 earnings showed InP revenue rising sharply from $3.5M in Q2 to about $13M in Q3. InP backlog passed $49M, and non-GAAP gross margin improved to 22.4%.
Aug 2025The Q2 2025 filing showed gross margin improving from negative 6.4% in Q1 to 8.0% in Q2. It also confirmed severe tariff pressure, with tariffs on some products reaching 100%.
Jul 2025Q2 earnings supported the China AI demand case, with InP revenue inside China nearly doubling sequentially. North America remained only 1% of revenue.
02 Business model

Special wafers, hard supply chains

AXTI makes money by selling high-performance wafers made from materials such as indium phosphide, gallium arsenide, and germanium. These are not standard silicon wafers. They are used when speed, light handling, or power conversion matters more than low cost.

Quality is the moat. The company focuses on very low EPD, which means fewer crystal defects in the wafer. Fewer defects can help customers get more working devices from each wafer, especially as optical chips get larger and harder to make.

AXTI is also vertically integrated. It designs its own crystal growth furnaces and uses raw material joint ventures for supply. JinMei has begun refining high-purity indium, which gives AXTI more direct control over a key input for InP.

That control helps, but it does not remove the main break points. If export permits lag, if tariffs stay high under Section 232 or Section 301, or if the capacity ramp hurts yields, the growth story can slow quickly.

03 Product portfolio

Where the wafers go

Growth engine

Indium phosphide

InP is the main growth driver. It is used in high-speed optical connectivity for AI data centers, and management says backlog has passed $100M.

Growth engine

Iron-doped InP

Iron-doped substrates are now about 40% of the large-diameter InP mix. This richer mix is helping gross margin as customers build more advanced optical devices.

Steady

Gallium arsenide

GaAs is used in VCSELs, HBT power amplifiers, and LiDAR. AXTI is selling 8-inch GaAs in small quantities, but U.S.-bound permits remain a pressure point.

Steady

Germanium

Germanium substrates are mainly used for satellite solar cells. This is a more mature product line than InP.

Cash cow

Raw materials

AXTI’s consolidated raw material joint ventures supply materials to the industry and support its own wafer production. JinMei now refines high-purity indium.

Option

6-inch InP development

AXTI is developing 6-inch InP. Larger wafers could matter if optical chip makers need bigger die and better factory throughput.

04 Business segments

Substrates carry the company

Substrate product group67%growing fast
Raw materials product group33%flat

The product mix below uses 2025 consolidated revenue from the Q1 2026 Form 10-Q: substrates were 67% and raw materials were 33%. Geography is more concentrated, with Asia Pacific at 78%, Europe at 21%, and North America at 1% in Q1 2026.

05 Risk factors

What could break the story

U.S. export permits stay stuck

High impact · Medium odds

North America fell to 1% of Q1 2026 revenue because direct U.S. shipments remain limited. Management expects InP permits to the U.S. eventually, but the timing is still uncertain. Supplying U.S. customers through other regions helps, but it may not replace direct access.

We watchWatch for China Ministry of Commerce approval of U.S.-bound InP permits and any rebound in North America revenue.

Capacity ramp misses the demand window

High impact · Medium odds

AXTI plans to double InP capacity in 2026 and again in 2027. That is a large operating challenge for a specialty materials company. If new furnaces take longer to qualify or yields fall, backlog may not convert into sales on time.

We watchWatch quarterly InP revenue, backlog conversion, customer qualification updates, and gross margin.

Tariffs keep pressure on costs

Medium impact · Medium odds

The U.S. Supreme Court invalidated IEEPA-based global tariffs in February 2026, which gave some relief. But tariffs under Section 232 and Section 301 remain in effect. Those rules can still hurt demand, pricing, or customer decisions.

We watchWatch company tariff disclosures and any changes to Section 232 or Section 301 treatment.

China demand cools after the build-out

Medium impact · Medium odds

Management estimates Chinese demand could rise from about 30% of global InP demand in Q2 2026 to about 40% by Q4 2026. That is strong, but it also raises the bar. If China’s AI infrastructure spending slows, AXTI could be left with fresh capacity and weaker pricing.

We watchWatch management comments on China InP share, order lead times, and new AI data center programs.

Tongmei IPO remains delayed

Medium impact · Medium odds

The planned STAR Market IPO for Tongmei is still pending. The IPO could help fund growth and give investors a clearer value marker for the China operating assets. A long delay would keep regulatory uncertainty in the story.

We watchWatch STAR Market filings, review status, and management timing comments.
06 Quick answers

In one breath

What does AXT make?

AXT makes compound semiconductor substrates. These are wafers made from materials such as indium phosphide, gallium arsenide, and germanium, which customers use to build optical devices, sensors, power amplifiers, and satellite solar cells.

Why is AXTI linked to AI data centers?

AI data centers need faster optical connections to move huge amounts of data. Indium phosphide substrates can be used in the optical devices that make those high-speed links work.

What is the biggest risk for AXTI?

The biggest risk is export control friction between China and the U.S. U.S.-bound InP permits are still pending, and North America was only 1% of Q1 2026 revenue.

Why is valuation a concern?

The bull case now assumes strong InP growth, successful capacity expansion, and better margins. If any of those slip, the stock may have less room for error.